Loading…
Securities purchase agreement signed with investors.
Equillium, Inc. (XNAS: EQ) announced today that it has entered into a securities purchase agreement with investors to secure up to $50 million in financing. The funds will be utilized to advance the development of its investigational drug candidate, EQ504.
The agreement outlines the terms under which the financing will be provided. No further details on the specific terms or conditions of the agreement were disclosed in the announcement.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.